Uterine Fibroids Clinical Trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1850 clinical trials
Featured trial
Alzheimer's Disease Family Based Study (AD FBS)

This study is looking for people who have Alzheimer’s or a related dementia, and also have family members who have Alzheimer’s. The study is interested in the genetics of Alzheimer’s risk.

Online studies
Accepts healthy volunteers
dementia
  • 2326 views
  • 31 Jan, 2023
  • 1 location
  • Online study
Featured trial
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)  

Primary Objectives:
<ul>
  • Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR
  • Cohort B: To evaluate the efficacy of BIVV020 in treatment of active AMR
  • tacrolimus
    corticosteroids
    kidney transplant
    ivig
    • 16 views
    • 02 Feb, 2023
    • 20 locations
    Featured trial
    Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)  

    Primary Objective:

    <ul>
  • To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who

    • 89 views
    • 27 Jan, 2023
    • 41 locations
    Featured trial
    Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (CLEan)

    Primary Objective:
    <ul>
  • Assess the efficacy of SAR443122 in cutaneous lupus erythematosus (CLE)
  • ul>
    Secondary Objectives:
    <ul>
  • Assess the effect of SAR443122

    • 25 views
    • 25 Jan, 2023
    • 5 locations
    Featured trial
    Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus (APATURA)

    the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include:

    <ul>
  • Study duration: 36 weeks
  • Treatment duration: 24 weeks

    lupus
    rash
    arthritis
    antinuclear antibody
    • 10 views
    • 25 Jan, 2023
    • 6 locations
    Featured trial
    Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

    Primary Objective:
    Primary population (former smokers cohort):
    <ul>
  • Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or

    • 758 views
    • 02 Feb, 2023
    • 90 locations
    Featured trial
    Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

    therapy of ICS/LABA will be withdrawn during the 12week randomized treatment period and resumed at the end of the IMP treatment period, as outlined below:

    <ul>
  • Screening period (4 weeks)
    • 5 views
    • 06 Jan, 2023
    • 23 locations
    Featured trial
    EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

    Primary Objective

    -To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smell

    Secondary Objectives

    <ul>
  • To

    • 42 views
    • 26 Jan, 2023
    • 69 locations
    Featured trial
    A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

    This is an open-label, monotherapy study of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1 rearrangement.  Subjects will receive a once daily (QD) dose of INCB054828 at 13.5 mg on a 2-week-on–therapy and 1-week-off–therapy schedule.  With Protocol Amendment 3, the administration schedule will be adjusted, and newly enrolled subjects will …

    FGFR1
    lymphoid malignancy
    myeloid neoplasm
    • 182 views
    • 19 Dec, 2022
    • 35 locations
    Featured trial
    SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients (CARMEN-LC03)  

    Primary Objectives:

    <ul>
  • Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cut-off date for each given analysis

    • 180 views
    • 06 Feb, 2023
    • 5 locations